d-alpha tocopherol has been researched along with Intraepithelial Prostatic Neoplasia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chin, J; Donnelly, B; Farley, A; Fleshner, NE; Gleave, M; Hersey, K; Jansz, K; Kapusta, L; Lacombe, L; Parulekar, WR; Siemens, DR; Tanguay, S; Trpkov, K; Tu, D | 1 |
Klein, EA; Thompson, IM | 1 |
Goeman, L; Joniau, S; Oyen, R; Ponette, D; Roskams, T; Van der Aa, F; Van Poppel, H | 1 |
Basler, J; Hensley, D; Higgins, B; Jenkins, CA; Leach, R; Pollock, B; Thompson, IM; Troyer, D; von Merveldt, D | 1 |
Lucia, MS; Sakr, WA | 1 |
Goeman, L; Joniau, S; Lerut, E; Oyen, R; Roskams, T; Van Poppel, H | 1 |
Barnes, S; Brawley, OW; Parnes, H | 1 |
4 review(s) available for d-alpha tocopherol and Intraepithelial Prostatic Neoplasia
Article | Year |
---|---|
Chemoprevention of prostate cancer: an updated view.
Topics: 5-alpha Reductase Inhibitors; Chemoprevention; Humans; Male; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Selenium; Trace Elements; Vitamin E; Vitamins | 2012 |
Prostate cancer prevention: what do we know now and when will we know more?
Topics: Antioxidants; Biomarkers, Tumor; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Humans; Male; Predictive Value of Tests; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk Factors; Selenium; Vitamin E | 2003 |
Potential pathologic markers for prostate chemoprevention studies.
Topics: Adenocarcinoma; Aged; Biomarkers, Tumor; Chemoprevention; Dietary Supplements; Humans; Male; Middle Aged; Neovascularization, Pathologic; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Risk Assessment; Selenium; Sensitivity and Specificity; Survival Analysis; Vitamin E | 2004 |
The future of prostate cancer prevention.
Topics: 5-alpha Reductase Inhibitors; Adenocarcinoma; Adult; Aged; Androgen Antagonists; Androgens; Anticarcinogenic Agents; Antioxidants; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Diet; Double-Blind Method; Enzyme Inhibitors; Finasteride; Forecasting; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms, Hormone-Dependent; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk; Selenium; Soybean Proteins; Treatment Outcome; Vitamin A; Vitamin D; Vitamin E | 2001 |
3 trial(s) available for d-alpha tocopherol and Intraepithelial Prostatic Neoplasia
Article | Year |
---|---|
Progression from high-grade prostatic intraepithelial neoplasia to cancer: a randomized trial of combination vitamin-E, soy, and selenium.
Topics: Disease Progression; Disease-Free Survival; Double-Blind Method; Humans; Male; Middle Aged; Patient Compliance; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Selenium; Soybean Proteins; Testosterone; Vitamin E | 2011 |
Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?
Topics: Aged; Biopsy, Needle; Follow-Up Studies; Humans; Immunohistochemistry; Male; Middle Aged; Prognosis; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Risk Factors; Selenium; Vitamin E | 2003 |
Effect of nutritional supplement challenge in patients with isolated high-grade prostatic intraepithelial neoplasia.
Topics: Adult; Aged; Dietary Supplements; Follow-Up Studies; Humans; Isoflavones; Male; Middle Aged; Neoplasm Staging; Prospective Studies; Prostate-Specific Antigen; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Risk Factors; Selenium; Soy Foods; Treatment Outcome; Vitamin E | 2007 |